W. David Bradford

MedicinePharmacology, Toxicology and PharmaceuticsEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021”.

Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021

JAMA Health Forum(2022)10.1001/jamahealthforum.2022.1821

N/A

0.330DataRank · unranked

8 citations

Kao‐Ping Chua, Barbara Andraka‐Christou, W. David Bradford, Kosali Simon, Thủy Nguyễn

Time Preference for Immediate Gratification: Associations With Low Medication Adherence and Uncontrolled Blood Pressure

American Journal of Hypertension(2021)10.1093/ajh/hpab175

N/A

0DataRank · unranked

14 citations

Erin Peacock, W. David Bradford, Brice Labruzzo Mohundro, Leslie S. Craig, Samantha O’Connell +4 more

Analysis of US County Characteristics and Clinicians With Waivers to Prescribe Buprenorphine After Changes in Federal Education Requirements

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.37912

N/A

0DataRank · unranked

6 citations

Barbara Andraka‐Christou, Camila L. Arnaudo, W. David Bradford, Kosali Simon, Joanne Spetz +1 more

Buprenorphine Treatment For Opioid Use Disorder: Comparison Of Insurance Restrictions, 2017–21

Health Affairs(2023)10.1377/hlthaff.2022.01513

N/A

0DataRank · unranked

27 citations

Kosali Simon, W. David Bradford, Thủy Nguyễn, Barbara Andraka‐Christou